HCI Group Stock And 2 Underfollowed Financial Stocks For Higher Rate Markets
This article identifies three underfollowed small-cap financial stocks—Maximus (MMS), Exzeo Group (XZO), and HCI Group (HCI)—that could thrive in a high-interest-rate environment. These companies, highlighted from the "High Quality Undiscovered Gems" screener, offer resilience and growth potential by operating in areas like government services modernization and InsurTech, despite potential risks like contract concentration or reliance on external factors. The article suggests these stocks could be valuable additions to a long-term portfolio before they gain widespread institutional attention.
How Investors Are Reacting To Maximus (MMS) Q3 Results And Updated 2026 Profit Guidance
Maximus Inc. (MMS) reported Q3 fiscal results and updated its full-year 2026 guidance, with revenue projected to be US$5.2–US$5.35 billion and net income US$376–US$392 million. The company reaffirmed its focus on disciplined acquisitions and share repurchases within a target net debt ratio of 2x–3x. This strategy aims to expand capabilities and customer access, driving revenue synergies and maintaining financial stability amid potential contract volume and budget pressures.
How Investors Are Reacting To Maximus (MMS) Q3 Results And Updated 2026 Profit Guidance
Maximus, Inc. reported its Q3 results with strong revenue and net income, and updated its 2026 full-year guidance, which includes revenue between US$5.2 billion and US$5.35 billion. The company emphasized its continued focus on disciplined acquisitions and share repurchases, aiming for revenue synergies while maintaining a net debt ratio of 2x-3x. This strategy reinforces the investment narrative centered on government outsourcing, margin improvement through technology, and controlled capital deployment, with some analysts projecting significant upside to its current stock price.
Q3 2026 Maximus Inc Earnings Call Transcript
Maximus Inc. (MMS) reported strong Q3 fiscal 2026 results with revenue aligning with expectations and adjusted EPS showing an increase. Despite improvements in adjusted EBITDA margin and US Federal Services operating margin, a customer-directed pause in performance incentives on the VA Medical Disability Exam (VAMDE) program is expected to negatively impact Q4 and Q1 fiscal 2027 earnings, leading to a revised EPS guidance. The company faces challenges including declining revenues in some segments, negative cash flow from operations due to administrative delays, and a slower pace of new contract signings.
Maximus (MMS) Flags Revenue Uncertainty, Is The Stock Still Undervalued?
Maximus (MMS) has drawn investor attention after its fiscal 2026 third-quarter results and updated guidance indicated revenue near the lower end of expectations, citing contract delays and weaker award conversion. Despite a 35.17% year-to-date share price decline, the company is still considered 43.9% undervalued with a fair value of $100 based on expectations of expanded demand due to new federal legislation. However, this valuation depends on timely contract rollouts and assumes no insourcing or client shifts to competitors.
Walleye Capital LLC Takes Position in Maximus, Inc. $MMS
Walleye Capital LLC has acquired a new stake in Maximus, Inc. (NYSE:MMS), purchasing 384,021 shares valued at approximately $20.6 million. This move comes as institutional investors collectively own 97.21% of Maximus, despite recent analyst downgrades leading to a "Reduce" consensus rating for the stock. Maximus recently reported quarterly EPS of $2.22, exceeding expectations, but revenue decreased by 5.1% year-over-year to $1.28 billion.
Maximus, Inc. $MMS Shares Sold by Bank of America Corp DE
Bank of America Corp DE reduced its stake in Maximus, Inc. (MMS) by 19.6% in the first quarter, selling 137,118 shares and retaining 563,486 shares valued at $36.1 million. Maximus reported quarterly EPS of $2.22, beating estimates, but revenue of $1.28 billion missed expectations and was down 5.1% year-over-year. The company also declared a quarterly dividend of $0.33, while analysts have given the stock an average "Reduce" rating.
Maximus (MMS): Fuller & Thaler Asset Management discloses 5.14% ownership stake
Fuller & Thaler Asset Management, Inc. has reported a beneficial ownership stake of 5.14% in MAXIMUS, INC. (MMS), holding 2,702,709.97 shares. The firm exercises sole voting power over 2,655,263.97 shares and sole dispositive power over all 2,702,709.97 beneficially owned shares. This disclosure was made via a SCHEDULE 13G SEC filing signed by Hanna Zanoni, Chief Compliance Officer.
Precision Trading with Maximus Inc. (MMS) Risk Zones
The article provides a detailed analysis of Maximus Inc. (MMS) with a focus on risk zones for precision trading. It highlights weak sentiment across all horizons, supporting a short bias, and outlines specific institutional trading strategies including long, breakout, and short positions with defined entry, target, and stop-loss levels. The analysis, generated by AI models, also includes multi-timeframe signal analysis indicating support and resistance levels.
Maximus (MMS) Q3 2026 Earnings Call Transcript
Maximus (MMS) reported Q3 2026 earnings, meeting revenue expectations but revising full-year EPS guidance downward due to a temporary suspension of performance incentives on a VA contract. Despite this, the company projects a return to positive organic growth in its U.S. Services segment in Q4 2026 and continues to prioritize technology investments, AI integration, and expansion into defense markets to diversify revenue and improve margins. Management expressed confidence in securing the VA MDE rebid and highlighted strong engagement in SNAP and Medicaid-related opportunities driven by H.R. 1 legislation.
Maximus (NYSE:MMS) Downgraded by Zacks Research to "Strong Sell"
Zacks Research has downgraded Maximus (NYSE:MMS) to a "Strong Sell" rating, with other analysts also lowering their assessments, resulting in an overall "Reduce" rating from MarketBeat. Maximus shares opened at $54.45, near their 12-month low, and the company reported quarterly EPS that slightly beat expectations but revenue that missed estimates and declined year-over-year. Institutional investors continue to hold a significant portion of the company's stock despite the downgrades and mixed financial performance.
Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?
Maximus (MMS) stock trades at a deep earnings discount, but this reflects near-term uncertainty due to federal procurement delays and contract sensitivity. While the company has a strong sales pipeline and improved liquidity, its current Zacks Rank #5 (Strong Sell) and unfavorable earnings estimate trends suggest caution, despite attractive valuation and fundamental characteristics. The article advises patience until estimate trends improve.
Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?
Maximus, Inc. (MMS) presents a complex investment case with a low valuation due to a deep earnings discount, but faces significant risks from federal procurement delays and contract sensitivity, leading to downward earnings estimate revisions. Despite a large sales pipeline, conversion risk is high, and while liquidity is stable, the company's Zacks Rank #5 (Strong Sell) suggests caution for investors until estimate trends improve.
Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?
Maximus, Inc. (MMS) presents a complex investment case due to its deep earnings discount and favorable fundamental Style Scores, contrasted with near-term uncertainty stemming from federal procurement delays and contract sensitivity. The company's valuation is significantly lower than its industry and historical median, reflecting weaker growth visibility, despite solid earnings growth and efficiency initiatives. Investors are advised to exercise patience until earnings estimate trends improve, despite the attractive valuation and strong operational indicators.
Can Maximus Weather the VA Contract Hit and Rebuild Earnings Momentum?
Maximus, Inc. (MMS) faces a near-term earnings setback due to a temporary pause in performance incentives for a major Department of Veterans Affairs contract, which significantly contributed to profitability. This has led to a reduction in fiscal 2026 adjusted earnings and free cash flow guidance. While the company benefits from operating improvements in other segments and technology-driven efficiencies, the impact of federal contract changes highlights its sensitivity to government programs.
Enterprise value to revenue forward of Maximus, Inc. – NYSE:MMS
The article focuses on the enterprise value to revenue forward for Maximus, Inc. (NYSE: MMS) as presented on TradingView. It appears to be a financial data snippet, showing key information about the company's financials within the context of market data. The content is primarily a listing of navigation and footer elements from the TradingView platform, with the actual financial data point being the core focus.
Did Lowered 2026 Guidance After VA Incentive Pause Just Shift Maximus' (MMS) Investment Narrative?
Maximus, Inc. (MMS) recently updated its fiscal 2026 guidance to the lower end of previous estimates after the Department of Veterans Affairs paused performance incentives on its Medical Disability Exam program. This decision highlights the company's reliance on government contracts and how shifts in their structure can significantly impact earnings, even as quarterly margins improve. The revised outlook underscores the inherent risks in Maximus's investment narrative, particularly its dependency on a few highly structured contracts.
Did Lowered 2026 Guidance After VA Incentive Pause Just Shift Maximus' (MMS) Investment Narrative?
Maximus, Inc. (MMS) recently lowered its fiscal 2026 guidance following a pause in performance incentives on its VA Medical Disability Exam program. This decision highlights the company's reliance on structured government contracts, which can significantly impact earnings despite improving quarterly EPS and a strong pipeline. Investors should consider how this shift in contract terms affects Maximus' long-term investment narrative and analyst expectations.
Did Lowered 2026 Guidance After VA Incentive Pause Just Shift Maximus' (MMS) Investment Narrative?
Maximus, Inc. reported Q3 results and updated its fiscal 2026 guidance downwards due to a pause in performance incentives on its VA Medical Disability Exam program. This shift highlights the company's reliance on government contracts and how changes in these structures can significantly impact earnings, potentially reshaping its investment narrative despite improving quarterly EPS. The revised outlook suggests that even with a strong pipeline, contract modifications can temper full-year expectations and complicate the path to consistent earnings.
Janus Henderson Group PLC Decreases Holdings in Maximus, Inc. $MMS
Janus Henderson Group PLC significantly reduced its stake in Maximus, Inc. by 95.4% in the first quarter, selling nearly half a million shares. Despite this, Maximus exceeded fiscal Q3 EPS expectations but saw revenue decline year-over-year and lowered its fiscal 2026 EPS guidance, leading to an average "Hold" rating from analysts. The company also announced a quarterly dividend of $0.33 per share.
Maximus (NYSE:MMS) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS
Maximus (NYSE:MMS) announced its quarterly earnings, reporting an adjusted EPS of $2.22, exceeding analyst expectations by $0.01, though revenue of $1.28 billion missed estimates and was down 5.1% year-over-year. The company lowered its fiscal 2026 adjusted EPS guidance to $7.90–$8.20, partially due to a temporary pause in VA Medical Disability Exam performance incentives. Despite the revenue miss and reduced profit outlook, Maximus maintains positive cash flow guidance and expects U.S. Services to return to mid-single-digit organic growth, driven by Medicaid-related outreach, AI solutions, and defense opportunities.
Reinhart Partners LLC. Purchases 1,127,346 Shares of Maximus, Inc. $MMS
Reinhart Partners LLC. significantly increased its stake in Maximus, Inc. (NYSE:MMS) by 131.8% in the second quarter, acquiring an additional 1.13 million shares to hold nearly 2 million shares valued at $106.6 million. This makes Maximus its 18th largest holding, representing 2.4% of its investment portfolio. The health services provider recently reported Q3 adjusted EPS of $2.22, beating estimates, but revenue fell 5.1% year-over-year to $1.28 billion and management reduced fiscal 2026 EPS guidance to $7.90–$8.20.
The Manufacturers Life Insurance Company Has $3.24 Million Stake in Maximus, Inc. $MMS
The Manufacturers Life Insurance Company significantly reduced its stake in Maximus, Inc. (NYSE:MMS) by 85.2% in the first quarter, now holding 50,540 shares valued at $3.24 million. Maximus reported fiscal Q3 adjusted EPS of $2.22, exceeding estimates, but revenue declined by 5.1% year-over-year to $1.28 billion, missing consensus. Analysts have largely maintained a "Hold" rating for the stock after recent downgrades, and the company issued a lower fiscal 2026 EPS guidance.
FMR LLC discloses 10.6% Maximus Inc (MMS) ownership in amended 13G
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a 10.6% beneficial ownership in Maximus Inc (MMS) common stock as of June 30, 2026. This equates to 5,544,431.76 shares, with FMR LLC holding sole voting power over 4,624,665.54 shares and sole dispositive power over all 5,544,431.76 shares. The filing indicates that other parties may have economic interests in these shares, but none exceed five percent of the class.
Maximus Q3 Earnings Beat Estimates, Increase Year Over Year
Maximus (MMS) reported mixed third-quarter fiscal 2026 results, with earnings beating estimates but revenues falling short. The company's adjusted earnings per share increased year-over-year, despite a decline in overall revenues due to factors like reduced natural disaster support and temporary clinical volume surges in the prior year. Maximus also lowered its fiscal 2026 earnings guidance due to a temporary contractual modification with a major federal customer.
Maximus, Inc. $MMS Stock Position Lifted by Quantinno Capital Management LP
Quantinno Capital Management LP significantly increased its stake in Maximus, Inc. by 413.1% in the first quarter, now holding 76,181 shares valued at approximately $4.9 million. This move comes as institutional investors collectively own 97.21% of the company. Maximus reported strong quarterly earnings of $2.22 per share, exceeding estimates, and declared a quarterly dividend of $0.33 per share, equivalent to a 2.3% yield, despite revenue falling short of expectations.
Maximus Q3 FY26 slides: margins expand but guidance cut on VA contract
Maximus (NYSE: MMS) reported Q3 FY26 results with margin expansion and an EPS beat, but cut its full-year profit outlook due to a temporary contractual modification with a major federal customer, causing its stock to drop by 10.85%. Despite the guidance cut, the company highlighted operational improvements, a substantial opportunity pipeline, and strategic growth initiatives in state programs, AI, and defense markets. Management expressed confidence in resolving cash flow timing challenges and reiterated long-term growth objectives.
Maximus: Fiscal Q3 Earnings Snapshot
Maximus Inc. (MMS) reported fiscal third-quarter net income of $103.6 million, or $1.95 per share. Adjusted earnings of $2.22 per share surpassed Wall Street expectations of $2.20 per share. However, the company's revenue of $1.28 billion missed forecasts, leading Maximus to project full-year revenue between $5.2 billion and $5.35 billion.
MaxHP to advance human performance for the modern warfighter
Maximus and Endurion have launched MaxHP, a strategic joint venture designed to optimize human performance for the United States Special Operations Command (USSOCOM) Enterprise. MaxHP aims to support warfighters and their families by integrating physical, cognitive, and behavioral readiness through embedded practitioners who understand the special operations environment. This initiative combines Maximus's infrastructure with Endurion's SOF-operator heritage to enhance mission readiness, resilience, and long-term force effectiveness.
Earnings Flash (MMS) Maximus, Inc. Reports Q3 Revenue $1.28B, Vs. FactSet Est of $1.33B
Maximus, Inc. (MMS) announced its Q3 revenue, reporting $1.28 billion, which fell short of FactSet's estimate of $1.33 billion. This earnings flash provides key financial figures for the company's recent quarter.
MAXIMUS, INC. 2026: Revenue $1.28B, EPS $1.95— 10-Q Summary
MAXIMUS, INC. (MMS) reported its Q2 2026 results, showing revenue of $1.28 billion, a 5.1% decrease year-over-year, and diluted EPS of $1.95, an increase of 4.8%. The revenue decline was primarily due to lower volumes in transaction-based contracts and reduced short-term disaster work, while net income slightly decreased. The company expects organic growth to return in Q4.
Maximus Reports Fiscal Year 2026 Third Quarter Results
Maximus (NYSE: MMS) reported its fiscal year 2026 third-quarter results, showing strong earnings despite a slight revenue dip compared to the prior year. The company reiterated its full-year revenue guidance but updated its earnings and free cash flow guidance due to a temporary contractual modification on a major federal program. Maximus's CEO, Bruce Caswell, highlighted the business's resilience and ongoing opportunities in AI-enabled solutions, SNAP-related offerings, and defense markets.
Maximus (NYSE:MMS) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings
Maximus (NYSE:MMS) reported Q2 CY2026 sales of $1.28 billion, missing Wall Street estimates and representing a 5.1% year-on-year decline. Despite the revenue miss, the company's non-GAAP profit of $2.22 per share slightly beat consensus estimates. Maximus reconfirmed its full-year revenue guidance but lowered its Adjusted EPS guidance, leading to a 3.6% stock dip post-announcement.
Maximus (MMS) Q3 Earnings Beat Estimates
Maximus (MMS) reported Q3 earnings of $2.22 per share, surpassing the Zacks Consensus Estimate of $2.2 per share, representing a 0.91% surprise. However, the company's revenue of $1.28 billion for the quarter ended June 2026 missed the Zacks Consensus Estimate by 3.2%. Despite underperforming the market year-to-date with a 26.8% loss, Maximus currently holds a Zacks Rank #3 (Hold), indicating an expectation to perform in line with the market.
Maximus beats Q3 earnings but cuts guidance on contract change
Maximus Inc. reported Q3 adjusted earnings per share of $2.22, surpassing analyst estimates, but revenue of $1.28 billion fell short. The company cut its full-year adjusted EPS guidance due to a temporary contractual modification on a major federal program, despite strong adjusted EBITDA margins and continued investment in growth. Maximus reiterated its fiscal 2026 revenue guidance and updated free cash flow projections.
Maximus: Fiscal Q3 Earnings Snapshot
Maximus Inc. (MMS) reported fiscal third-quarter net income of $103.6 million, or $1.95 per share, exceeding analyst expectations with adjusted earnings of $2.22 per share. However, the company's revenue of $1.28 billion fell short of Street forecasts. Maximus anticipates full-year revenue to be between $5.2 billion and $5.35 billion.
Maximus earnings on deck amid AI push and revenue headwinds
Maximus Inc. is set to report its fiscal third-quarter results, with analysts expecting $2.18 EPS on $1.33 billion revenue. Investors will focus on the company's ability to sustain margin gains from AI investments like Accuracy Assistant amidst revenue headwinds and a projected 1.5% decline in year-over-year revenue. Despite a 37% stock tumble, analysts maintain a bullish outlook with a $105 price target, viewing the current price as an attractive entry point.
Maximus Earnings: What To Look For From MMS
Maximus (MMS) is set to report its earnings this Thursday morning. The government services provider missed revenue expectations last quarter but beat EPS estimates. Analysts anticipate a 1.6% year-on-year revenue decline for the upcoming quarter, and the stock has seen positive sentiment, with its share price up 12.9% over the last month.
Maximus (MMS) Earnings Date and Reports 2026
Maximus (MMS) issued its Q2 2026 earnings on May 7, 2026, reporting an EPS of $2.07, surpassing analysts' estimates, although quarterly revenue of $1.31 billion was slightly below expectations. The company's earnings are projected to grow by 5.10% next year. Maximus's Q3 2026 earnings are estimated for August 6, 2026, with an accompanying conference call.
Maximus Data Breach Exposes Sensitive Personal Info Including SSNs
Maximus US Services Inc., a government services company, disclosed a data breach that exposed sensitive personal information due to a security incident involving the Nebraska Provider Data Management System (PDMS). The breach, discovered on April 27, 2026, compromised first and last names, dates of birth, and Social Security numbers. Maximus is offering affected individuals a free 24-month membership to Experian IdentityWorks for credit monitoring and identity protection.
Maximus Data Breach Lawsuit Investigation
Shamis & Gentile P.A. is investigating a data breach at Maximus US Services Inc., a large government services company, which occurred around April 27, 2026. This breach exposed sensitive personal information, including names, dates of birth, and Social Security numbers, through the Nebraska Provider Data Management System. Individuals affected by the breach may be entitled to compensation and are encouraged to submit a claim.
MAXIMUS Number of Employees 2026 | Employee Count & Headcount Data
MAXIMUS, Inc. (MMS) had approximately 36,490 employees worldwide as of March 2026, representing a 6.6% decline since 2023. Despite this reduction in headcount, the company is actively hiring, with 2,364 active job postings in 2026. The article details the company's workforce distribution by country, department, salary by region, and employee sentiment, noting that the United States holds the largest share of employees and overall sentiment is negative but improving.
Maximus Inc (MMS) Cash Flow
This article provides a detailed historical cash flow statement for Maximus Inc (MMS), covering quarterly and annual periods for operating, investing, and financing activities. It presents financial data including net income, capital expenditures, debt issuance, and dividend payments, along with year-over-year percentage changes. The article also includes a FAQ section defining key cash flow metrics and Maximus Inc's performance in these areas.
MMS|Maximus Inc|Price:60.940|Chg%:+1.270
This article provides a detailed company profile for Maximus Inc (MMS), an operator of government health and human services programs. It outlines the company's business scope across three segments: U.S. Services, U.S. Federal Services, and Outside the U.S., and includes financial data like market capitalization and P/E ratio, key executive information with shareholdings, and institutional ownership statistics.
Maximus Inc (MMS) Institutional Confidence
Maximus Inc (MMS) has an institutional shareholding score of 10.00, placing it first in the Professional & Commercial Services industry. Institutional investors hold 126.59% of shares, a 17.86% increase quarter-over-quarter. Chuck Royce is the largest institutional shareholder with 0.70% of outstanding shares.
Maximus Inc (MMS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for Maximus Inc (MMS), detailing its financial performance by region. As of March 4, 2025, the company generated $3.87 billion (83.51%) from the United States, $410.59 million (8.87%) from the United Kingdom, $180.00 million (3.89%) from the Rest of World, and $173.08 million (3.74%) from Australia. Data for business segments and profit contribution were not disclosed by the company.
Maximus Inc (MMS) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides a historical overview of dividend payouts and stock split events for Maximus Inc (MMS). It details quarterly cash dividends, including their gross amounts, record dates, payment dates, and ex-dividend dates, spanning from 2024 through 2026. The data indicates that Maximus Inc has distributed a total of 347.24 million USD in dividends over the past five years.
MAXIMUS, Inc. Revenue Breakdown – LS:907462
MAXIMUS, Inc. generated 4.63 billion EUR in revenue last year, with its United States Federal Services segment contributing 2.61 billion EUR. The U.S. was the largest regional contributor, accounting for 4.12 billion EUR of the total revenue. This article details the top segments and regional performance for the company.
How Maximus’ Higher Dividend Yield and Low Payout Ratio Could Shape MMS Investors’ Income Outlook
Maximus, Inc. recently increased its annualized dividend by 10%, resulting in a 2.29% yield with a low 17% payout ratio, exceeding industry and S&P 500 averages. This move, combined with forecasts for earnings growth in 2026 and stable fiscal 2026 revenue guidance, strengthens the company's income profile for investors focusing on government services demand. While supporting an attractive dividend, external factors like government budgets and contract volumes remain key risks.
MMS|Maximus Inc|Price:61.297|Chg%:+1.627
This article provides a comprehensive stock analysis of Maximus Inc (MMS) by TradingKey, highlighting its strong fundamentals, high growth potential, and fair valuation. The report notes high institutional ownership and a "Buy" rating from multiple analysts with a target price of $105.00. Despite good market performance, the technicals suggest the stock is trading sideways, making it suitable for range-bound swing trading.
